Ramaiah Memorial Hospital and Ramaiah Medical College became the center of global medical innovation with the inauguration of the Worldwide Network for Blood and Marrow Transplantation (WBMT) Symposium on Cell Therapy, Bengaluru 2025.
The WBMT—an international NGO in official relations with the World Health Organization (WHO)—launched this major scientific convention to spotlight the future of cellular therapies, including BMT and CAR-T. The event, jointly organized with the Ramaiah Bone Marrow Transplant and Cell Therapy Program (established in 2014), was inaugurated by K. B. Sivakumar, IAS, Commissioner of Health and Family Welfare Services, Government of Karnataka; Dr. Nagendra Swamy S. C., Chief Executive of Ramaiah Memorial Hospital & Healthcare Services, Gokula Educational Foundation (Medical); and Dr. Damiano Rondelli of Chicago, USA, President of the WBMT.
Also Read: Alkem Rolls Out De Simone Blend as Gut-Health Demand Rises
The symposium brings together leading clinicians, scientists, researchers, and global experts from the USA, Europe, the UK, Japan, Brazil, Australia, and India to foster dialogue, innovation, and international collaboration in CAR-T therapies, hematopoietic cell transplantation, and emerging cellular treatments.
This gathering represents a key milestone for Indian healthcare, emphasizing the nation’s progress in bone marrow transplantation and advanced cell-based therapies, including CAR-T and gene therapy for blood cancers and inherited blood disorders. Professor Damiano Rondelli, President of WBMT, noted that the symposium plays a critical role in building global capacity for transplantation and cell therapy.
He emphasized that bringing together experts from across the region would significantly enhance access to high-quality care for patients across Asia. In his inaugural remarks, Dr. Nagendra Swamy reaffirmed the institution’s dedication to expanding access to advanced cell therapies and strengthening India’s role as a leader in global healthcare innovation.
